Sindusfarma: tirelessly committed to international cooperation and knowledge dissemination

23 July 2021
brazil_large

“In an increasingly globalized world, the exchange of knowledge is crucial for the pharmaceutical industry,” said Nelson Mussolini, Sindusfarma’s chairman.

“Scientific knowledge is the raw material for development and the exchange of information in the regulatory area, and helps us to standardize norms, opening new horizons for cutting-edge technologies.”

With this in mind, Sindusfarma, the largest representative body of the pharmaceutical industry in Brazil, maintains cooperation agreements with institutions such as the Drug Information Association (DIA), the International Pharmaceutical Excipients Council (IPEC - Americas), Les Entreprises du Médicament (LEEM) and United States Pharmacopeia (USP), writes The Pharma Letter’s Latin American correspondent.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical